본문 바로가기

Gut distress and intervention via communications of SARS-CoV-2 with mucosal exposome

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopusSSCI
저널 순위
JCR Q1Scopus Q2
저널
FRONTIERS IN PUBLIC HEALTH11 · #1098774 · 2023
피인용
Web of Science 3Scopus 3
FWCI (Scopus)
0.14
JCR IF
JCR 2022 5.2
ISSN
2296-2565

저자

  1. 문유석제1저자교신저자Pusan Natl Univ, Dept Integrat Biomed Sci, Lab Mucosal Exposome & Biomodulat, Yangsan Si, South Korea

초록

Acute coronavirus disease 2019 (COVID-19) has been associated with prevalent gastrointestinal distress, characterized by fecal shedding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA or persistent antigen presence in the gut. Using a meta-analysis, the present review addressed gastrointestinal symptoms, such as nausea, vomiting, abdominal pain, and diarrhea. Despite limited data on the gut-lung axis, viral transmission to the gut and its influence on gut mucosa and microbial community were found to be associated by means of various biochemical mechanisms. Notably, the prolonged presence of viral antigens and disrupted mucosal immunity may increase gut microbial and inflammatory risks, leading to acute pathological outcomes or post-acute COVID-19 symptoms. Patients with COVID-19 exhibit lower bacterial diversity and a higher relative abundance of opportunistic pathogens in their gut microbiota than healthy controls. Considering the dysbiotic changes during infection, remodeling or supplementation with beneficial microbial communities may counteract adverse outcomes in the gut and other organs in patients with COVID-19. Moreover, nutritional status, such as vitamin D deficiency, has been associated with disease severity in patients with COVID-19 via the regulation of the gut microbial community and host immunity. The nutritional and microbiological interventions improve the gut exposome including the host immunity, gut microbiota, and nutritional status, contributing to defense against acute or post-acute COVID-19 in the gut-lung axis.

키워드

COVID-19SARS-CoV-2meta-analysisgastrointestinal symptomsgut-lung axismicrobiotanutritional interventionVITAMIN-DGASTROINTESTINAL SYMPTOMSANTIBODY-RESPONSESSARS CORONAVIRUSACE2MICROBIOTAEXPRESSIONCELLSRISK

식별자

Scopus EID
2-s2.0-85159546166
WoS UID
000978584400001